Intermediate-Dose Ara-C Plus G-CSF for Stem Cell Mobilization in Patients With Lymphoid Malignancies, Including Predicted Poor Mobilizers
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.269
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2013
Authors
Publisher
Springer Science and Business Media LLC